CompaniesIndicia Biotechnology

Indicia Biotechnology

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

45

By Phase

PHASE2: 1PHASE1/PHASE2: 1

By Status

NOT_YET_RECRUITING: 1COMPLETED: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2020

2021

2022

2023

2024

2025

2026

2027

2028

Today

Hover over trial bars to see details

Recent Trials

NCT07122648Lead Sponsor

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

PHASE2Not yet recruiting

36 participants

Started: Dec 31, 2025 · Completed: Apr 30, 2027

NCT04976140Lead Sponsor

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

PHASE1/PHASE2Completed

Started: Dec 15, 2021 · Completed: Oct 6, 2023

Related Companies

Platine Pharma Services

acquired